Shanghai Medicilon Inc Market Cap ($1.46 Billion)
Market Cap & Net Worth: Shanghai Medicilon Inc (688202)
Shanghai Medicilon Inc market cap. Shanghai Medicilon Inc (SHG:688202) has a market capitalization of $1.46 Billion (CN¥9.99 Billion) as of November 9, 2026. Listed on the SHG stock exchange, this China-based company holds position #7065 globally and #1462 in its home market, demonstrating a -2.91% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanghai Medicilon Inc's stock price CN¥74.38 by its total outstanding shares 134352184 (134.35 Million). Also see how efficiently does Shanghai Medicilon Inc generate cash for how efficiently the company converts equity into cash flow.
Shanghai Medicilon Inc Market Cap History (2019–2026)
Shanghai Medicilon Inc market cap history from 2019 to 2026. Data shows growth from $579.14 Million to $1.46 Billion (10.98% CAGR). Check today's stock price for Shanghai Medicilon Inc for real-time trading data and today's change.
Shanghai Medicilon Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shanghai Medicilon Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 688202 year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.95x
Shanghai Medicilon Inc's market cap is 0.95 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $579.14 Million | $449.39 Million | $66.57 Million | 1.29x | 8.70x |
| 2020 | $1.56 Billion | $665.96 Million | $129.39 Million | 2.34x | 12.06x |
| 2021 | $4.83 Billion | $1.17 Billion | $282.22 Million | 4.14x | 17.10x |
| 2022 | $2.99 Billion | $1.66 Billion | $338.24 Million | 1.80x | 8.84x |
| 2023 | $1.34 Billion | $1.37 Billion | -$33.21 Million | 0.98x | N/A |
| 2024 | $593.14 Million | $1.04 Billion | -$330.85 Million | 0.57x | N/A |
| 2025 | $1.11 Billion | $1.16 Billion | -$167.83 Million | 0.95x | N/A |
Competitor Companies of 688202 by Market Capitalization
Companies near Shanghai Medicilon Inc in the global market cap rankings as of November 9, 2026. Also see 688202 total assets for a full breakdown of the balance sheet.
Key companies related to Shanghai Medicilon Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #177 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #363 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #403 globally with a market cap of $69.36 Billion USD ( AU$98.02 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #177 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $547.09 |
| #363 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $904.35 |
| #403 | CSL Ltd | AU:CSL | $69.36 Billion | AU$202.04 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $254.19 |
Market Capitalization of Shanghai Medicilon Inc (2019–2026)
Market capitalization of Shanghai Medicilon Inc from 2019 to today. Between 2019 and today, Shanghai Medicilon Inc's market cap moved from $579.14 Million to $ 1.46 Billion, with a yearly change of 10.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.46 Billion | +31.88% |
| 2025 | CN¥1.11 Billion | +86.94% |
| 2024 | CN¥593.14 Million | -55.88% |
| 2023 | CN¥1.34 Billion | -55.06% |
| 2022 | CN¥2.99 Billion | -38.02% |
| 2021 | CN¥4.83 Billion | +209.30% |
| 2020 | CN¥1.56 Billion | +169.46% |
| 2019 | CN¥579.14 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 9th, 2026 the market cap of Shanghai Medicilon Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.46 Billion USD |
| MoneyControl | $1.46 Billion USD |
| MarketWatch | $1.46 Billion USD |
| marketcap.company | $1.46 Billion USD |
| Reuters | $1.46 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shanghai Medicilon Inc
Shanghai Medicilon Inc., a contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally. The company operates in Drug Discovery and Pharmaceutical Research, and Preclinical Research segments. It offers drug discovery, CMC development, preclinical research, biology, chemistry, catalyst screening, flow ch… Read more